(Q32118893)

English

Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ferrero D

1

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Foli C

2

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Giaretta F

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Argentino C

4

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Rus C

5

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Pileri A

6

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

422-429

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential complementation of Bcr-Abl point mutants with c-Myc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

BCR/ABL induces multiple abnormalities of cytoskeletal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of granulocyte colony-stimulating factor and its requirement for terminal divisions in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

BCR – ABL accelerates C2-ceramide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro culture studies of blood and marrow cells in chronic myeloid leukemia at different phases of the disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of in vitro maintenance of non-promyelocytic myeloid leukemia clonogenic cells by all-trans retinoic acid: modulating effects of dihydroxylated vitamin D3, alpha interferon and 'stem cell factor'

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of 13-cis retinoic acid and interferon-α in chronic myelogenous leukemia cells In vivo in patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402038

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402038

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32118893&oldid=2175456930"